Company Directory > Biotech > Medison Pharma
Medison Pharma is a global commercialization platform that provides a unified solution for biotech companies seeking to launch breakthrough therapies in international markets outside the U.S., Western Europe, and Japan. The company operates as a first-of-its-kind integrated platform, offering end-to-end services including regulatory affairs, medical affairs, market access, and commercial operations through a single, centrally managed partnership. Medison specializes in high-innovation segments such as oncology, rare diseases, and immunology. By leveraging its multi-regional infrastructure, Medison enables its partners—which include industry leaders like Amgen, Biogen, Vertex, and Alnylam—to reach patients in complex and fragmented markets like Israel, Canada, Central Eastern Europe (CEE), and recently expanded regions in APAC and LATAM.
CLASSIFICATION
Company Type:Biotech
Industry:Pharmaceuticals
Sub-Industry:Commercialization Platform & Distribution
SIZE & FINANCIALS
Employees:501-1000
Revenue:$500M-$1B
Founded:1996
Ownership:private
Status:operating
FUNDING
Stage:Late Stage
Total Raised:$100M+
Investors:Shamrock Capital Advisors, Meir Jakobsohn
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, mAb, RNAi, Gene therapy
Active Trials:15
Trial Phases:Phase 2: 2 | Phase 3: 8 | Phase 4: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Medison Canada, Medison CEE, Medison APAC
Key Partnerships:Alnylam Pharmaceuticals (Global multi-regional partnership), Vertex Pharmaceuticals (Cystic Fibrosis portfolio), Biogen (Neurology portfolio), Amgen (Oncology/General medicine), Immunocore (Kimmtrak), Rigel Pharmaceuticals (Tavalisse), Sarepta Therapeutics (Gene therapy)
COMPETITION
Position:Leader
Competitors:AOP Health, Clinigen Group, EUSA Pharma, Knight Therapeutics, Taro Pharmaceuticals
LEADERSHIP
Key Executives:
Meir Jakobsohn - Founder & Executive Chairman
Gil Gurfinkel - CEO
Shay Tamari - Chief Business Officer
Scientific Founders:Meir Jakobsohn
Board Members:Meir Jakobsohn, Representatives from Shamrock Capital
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Medison Pharma. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.